CANNAPHARMARX, INC. Cost of Revenue
CANNAPHARMARX, INC. (CPMD) reported Cost of Revenue of $414.66 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-18.
Financial Statements › Expense Statement
us-gaap:CostOfGoodsAndServicesSold · last filed 2026-08-18
- CANNAPHARMARX, INC. cost of goods and services sold for the quarter ending 2026-06-30 was $414.66K, a 51.38% decline year-over-year.
- CANNAPHARMARX, INC. cost of goods and services sold for the quarter ending 2026-03-31 was $1.04M, a 23.75% increase year-over-year.
- CANNAPHARMARX, INC. cost of goods and services sold for the quarter ending 2025-12-31 was $659.72K, a 69.64% decline year-over-year.
- CANNAPHARMARX, INC. cost of goods and services sold for the quarter ending 2025-09-30 was $1.10M, a 64.08% increase year-over-year.
- CANNAPHARMARX, INC. cost of goods and services sold for fiscal 2025 was $3.45M, a 8.20% decline from fiscal 2024.
- CANNAPHARMARX, INC. cost of goods and services sold for fiscal 2024 was $3.76M.
- CANNAPHARMARX, INC. cost of goods and services sold for fiscal 2023 was $0.00.
| Period end | Cost of Goods and Services Sold 3 month | Cost of Goods and Services Sold 6 month | Cost of Goods and Services Sold 9 month | Cost of Goods and Services Sold 12 month |
|---|---|---|---|---|
| 2026-06-30 | $414.66K 10-Q · filed 2026-08-18 | $1.45M 10-Q · filed 2026-08-18 | $2.11M derived: sum of 3 quarters · filed 2026-08-18 | $3.21M derived: sum of 4 quarters · filed 2026-08-18 |
| 2026-03-31 | $1.04M 10-Q · filed 2026-05-20 | $1.70M derived: sum of 2 quarters · filed 2026-05-20 | $2.79M derived: sum of 3 quarters · filed 2026-05-20 | $3.65M derived: sum of 4 quarters · filed 2026-08-18 |
| 2025-12-31 | $659.72K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $1.76M derived: sum of 2 quarters · filed 2026-03-31 | $2.61M derived: sum of 3 quarters · filed 2026-08-18 | $3.45M 10-K · filed 2026-03-31 |
| 2025-09-30 | $1.10M 10-Q · filed 2025-11-14 | $1.95M derived: sum of 2 quarters · filed 2026-08-18 | $2.79M 10-Q · filed 2025-11-14 | $4.96M derived: sum of 4 quarters · filed 2026-08-18 |
| 2025-06-30 | $852.82K 10-Q · filed 2026-08-18 | $1.69M 10-Q · filed 2026-08-18 | $3.86M derived: sum of 3 quarters · filed 2026-08-18 | $4.53M derived: sum of 4 quarters · filed 2026-08-18 |
| 2025-03-31 | $837.93K 10-Q · filed 2026-05-20 | $3.01M derived: sum of 2 quarters · filed 2026-05-20 | $3.68M derived: sum of 3 quarters · filed 2026-05-20 | $3.85M derived: sum of 4 quarters · filed 2026-05-20 |
| 2024-12-31 | $2.17M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $2.84M derived: sum of 2 quarters · filed 2026-03-31 | $3.01M derived: sum of 3 quarters · filed 2026-03-31 | $3.76M 10-K · filed 2026-03-31 |
| 2024-09-30 | $668.32K 10-Q · filed 2025-11-14 | $839.69K derived: sum of 2 quarters · filed 2025-11-14 | $1.58M 10-Q · filed 2025-11-14 | $1.30M derived: sum of 4 quarters · filed 2025-11-14 |
| 2024-06-30 | $171.36K 10-Q · filed 2025-08-14 | $913.70K 10-Q · filed 2025-08-14 | $634.61K derived: sum of 3 quarters · filed 2025-08-14 | $634.61K derived: sum of 4 quarters · filed 2025-08-14 |
| 2024-03-31 | $463.25K 10-Q · filed 2025-05-16 | $463.25K derived: sum of 2 quarters · filed 2025-05-16 | $463.25K derived: sum of 3 quarters · filed 2025-05-16 | |
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-10 | $0.00 derived: sum of 2 quarters · filed 2025-04-10 | $0.00 10-K · filed 2025-04-10 | |
| 2023-09-30 | $0.00 10-Q · filed 2024-11-14 | $0.00 10-Q · filed 2024-11-14 | ||
| 2023-03-31 | $0.00 10-Q · filed 2024-06-25 |